Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the cleantalk-spam-protect domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /wordpress/wp-includes/functions.php on line 6121 Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the divi-booster domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /wordpress/wp-includes/functions.php on line 6121 Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wpmudev domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /wordpress/wp-includes/functions.php on line 6121 Clinical trial shows wrist device significantly reduces tics in Tourette syndrome | DeMarle, Inc.

Clinical trial shows wrist device significantly reduces tics in Tourette syndrome

by | Jul 2, 2023 | Tourette Syndrome, Uncategorized

Clinical trial shows wrist device significantly reduces tics in Tourette syndrome

by University of Nottingham

The results of the clinical trial of a new wrist device designed to help control the symptoms of Tourette syndrome have shown it significantly reduces the severity and frequency of tics.

 The prototype wrist device, which was recently tried out by Lewis Capaldi, delivers to reduce the amount and severity of tics experienced by individuals with Tourette’s and was trialed by 121 people across the UK. The results have been announced in MedRxiv.

The device has been developed by scientists at the University of Nottingham and spin-out company Neurotherapuetics Ltd who have recently secured £1m in additional funding to commercialize the ‘Neupulse’ device with the aim of having a device and App available within the next 3 years.